PD
PORTNOY DAVID Chief Executive Officer
C-suite M
US US · SEC (Form 4)
€72,330
▲ Purchases (14 ops.)
Browse the detailed record of transactions filed by PORTNOY DAVID, Chief Executive Officer. Director active across 1 companies, notably Cryo Cell International INC. Aggregated, 18 filings have been logged. Total volume traded: €72k. The latest transaction was filed on 24 August 2021 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations 18 total
€167,332 67,816 shares @ €2.4674 0.57% mcap 34.5% of flow
Common Stock
SEC:0001209191-21-053500 · 24 Aug 2021
€167,332 67,816 shares @ €2.4674 0.57% mcap 17.2% of flow
Common Stock
SEC:0001209191-21-053500:0 · 24 Aug 2021
€1,268 158 shares @ €8.027 0.0043% mcap 0.3% of flow
Common Stock
SEC:0001209191-21-048202 · 23 Jul 2021
Ideal exit: 19 Apr 2022 (T+270) €1,268 158 shares @ €8.027 0.0043% mcap 0.1% of flow
Common Stock
SEC:0001209191-21-048202:0 · 23 Jul 2021
Ideal exit: 19 Apr 2022 (T+270) €783 100 shares @ €7.8304 0.0027% mcap 0.2% of flow
Common Stock
SEC:0001209191-21-047409 · 19 Jul 2021
Ideal exit: 15 Apr 2022 (T+270) €783 100 shares @ €7.8304 0.0027% mcap 0.1% of flow
Common Stock
SEC:0001209191-21-047409:0 · 19 Jul 2021
Ideal exit: 15 Apr 2022 (T+270) €6,711 946 shares @ €7.0941 0.023% mcap 1.4% of flow
Common Stock
SEC:0001209191-21-036311 · 27 May 2021
Ideal exit: 21 Feb 2022 (T+270) €6,711 946 shares @ €7.0941 0.023% mcap 0.7% of flow
Common Stock
SEC:0001209191-21-036311:0 · 27 May 2021
Ideal exit: 21 Feb 2022 (T+270) €281,629 200,000 shares @ €1.4081 0.97% mcap 58.1% of flow
Common Stock
SEC:0001209191-21-035964 · 24 May 2021
€281,629 200,000 shares @ €1.4081 0.97% mcap 29.0% of flow
Common Stock
SEC:0001209191-21-035964:0 · 24 May 2021
€6,920 1,000 shares @ €6.92 0.024% mcap 1.4% of flow
Common Stock
SEC:0001209191-21-035737 · 21 May 2021
Ideal exit: 15 Feb 2022 (T+270) €6,920 1,000 shares @ €6.92 0.024% mcap 0.7% of flow
Common Stock
SEC:0001209191-21-035737:0 · 21 May 2021
Ideal exit: 15 Feb 2022 (T+270) €14,159 2,000 shares @ €7.0794 0.049% mcap 2.9% of flow
Common Stock
SEC:0001209191-21-033857 · 13 May 2021
Ideal exit: 7 Feb 2022 (T+270) €14,159 2,000 shares @ €7.0794 0.049% mcap 1.5% of flow
Common Stock
SEC:0001209191-21-033857:0 · 13 May 2021
Ideal exit: 7 Feb 2022 (T+270) €3,181 457 shares @ €6.9599 0.011% mcap 0.7% of flow
Common Stock
SEC:0001209191-21-032094 · 10 May 2021
Ideal exit: 4 Feb 2022 (T+270) €3,181 457 shares @ €6.9599 0.011% mcap 0.3% of flow
Common Stock
SEC:0001209191-21-032094:0 · 10 May 2021
Ideal exit: 4 Feb 2022 (T+270) €3,143 446 shares @ €7.0473 0.011% mcap 0.6% of flow
Common Stock
SEC:0001209191-21-030364 · 3 May 2021
Ideal exit: 28 Jan 2022 (T+270) €3,143 446 shares @ €7.0473 0.011% mcap 0.3% of flow
Common Stock
SEC:0001209191-21-030364:0 · 3 May 2021
Ideal exit: 28 Jan 2022 (T+270) About PORTNOY DAVID David Portnoy is an insider at Cryo Cell International Inc.